Latest News

Tools and Resources Articles

Filter by:
Topic
Clear filter
Tools and Resources

Standardization of IDS Key Performance Indicators and Metrics; Results of a HOPA IDS SIG Survey

April 10, 2024

The Hematology/Oncology Pharmacy Association has helped establish practical guidance for Investigational Services metrics and site utilization.

X-ray of brain with desmoid tumors
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Nirogacestat (Ogsiveo)

December 27, 2023

Brooke Lochridge, PharmD ,PGY-2 Oncology Pharmacy Resident, of Tristar Centennial Medical Center, Nashville, TN, and Colleen McCabe, PharmD, BCOP, Oncology Clinical Specialist, Sarcoma & Melanoma from Vanderbilt University Medical Center, Nashville, TN w

high-risk neuroblastoma
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Eflornithine for High-Risk Neuroblastoma

December 13, 2023

Taylor Gullickson, PharmD, PGY1 Pharmacy Resident and Alexis Kuhn, PharmD, BCOP, Pediatric Oncology Pharmacist, from Mayo Clinic Rochester, Minnesota write about Eflornithine for High-Risk Neuroblastoma.

close up photo of colon cancer cells
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Fruquintinib

December 08, 2023

Hunter Sowell, PharmD, PGY-2 Oncology Pharmacy Resident and Sarah Cimino, PharmD, BCOP, Clinical Pharmacist Specialist, Gastrointestinal Oncology, both from Vanderbilt University Medical Center, write about fruquintinib.

Woman pointing to x-ray of metastatic breast cancer diagram
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Capivasertib

November 26, 2023

Rachel B Allen, PharmD, PGY1 Pharmacy Resident and Sarah Cimino, PharmD, BCOP, Clinical Pharmacist Specialist, Gastrointestinal Oncology, both from Vanderbilt University Medical Center, write about Capivasertib.

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Niraparib and Abiraterone Acetate (Akeega™)

November 12, 2023

Mallori Anderson, PharmD, PGY2 and Christine Barrett, PharmD, BCOP, from the Mary Babb Randolph Cancer Center write about Akeega™

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Elranatamab-bcmm

November 06, 2023

Emily Lo, PharmD Candidate and Chung-Shien Lee, PharmD, BCPS, BCOP at St John’s University College of Pharmacy and Health Sciences write about Elranatamab-bcmm).

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Talquetamab-tgvs

August 09, 2023

Marguerite Courtney, PharmD Candidate 2024 and Bradley Yelvington, PharmD, BCOP from University of Tennessee discuss talquetamab-tgvs

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Epcoritamab-bysp

May 19, 2023

Shaniya Pleasant, PharmD/MHCI Candidate and Bradley Yelvington, PharmD, BCOP from Vanderbilt University Medical Center write about epcoritamab-bysp

Tools and Resources Late Breaking News

Immune Checkpoint Inhibitors Make Great Strides in Hepatocellular Carcinoma

May 18, 2023

STRIDE presents an alternative first-line choice for patients with unresectable HCC with a manageable side effect profile and a 22% reduction in risk of death over sorafenib

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Retifanlimab-dlwr

March 22, 2023

Bernard Marini, PharmD, BCOP, Clinical Pharmacist Specialist at University of Michigan College of Pharmacy writes about Retifanlimab-dlwr.

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Pirtobrutinib

January 27, 2023

Andy Hawn, 2025 PharmD Candidate and Erin Kelley, PharmD, BCOP at the Masonic Cancer Clinic Infusion Pharmacy write about Pirtobrutinib